About Konkuk University Chungju Hospital
Clinical Trials at Konkuk University Chungju Hospital
During the past decade, Konkuk University Chungju Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Konkuk University Chungju Hospital" #1 sponsor was "Chong Kun Dang Pharmaceutical" with 1 trials, followed by "Gilead Sciences" with 1 trials
sponsored, "Konkuk University Medical Center" with 1 trials sponsored, "Korea Otsuka Pharmaceutical Co., Ltd." with 1 trials sponsored and "Seung-Jung Park"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Konkuk University Chungju Hospital"
#1 collaborator was "Amg Korea Co. Ltd." with 1 trials as a collaborator and "CardioVascular Research Foundation, Korea" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Konkuk University Chungju Hospital
According to Clinical.Site data, the most researched conditions in "Konkuk University Chungju Hospital" are
"Angioplasty, Transluminal, Percutaneous Coronary" (1 trials), "Antipsychotics" (1 trials), "Aripiprazole" (1 trials), "Coronary Artery Disease" (1 trials) and "Hepatitis B, Chronic" (1 trials). Many other conditions were trialed in "Konkuk University Chungju Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Konkuk University Chungju Hospital
Most popular intervention types in "Konkuk University Chungju Hospital" are "Drug" (4 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Abilify maintena" (1 trials), "Baraclude Tab. 0.5mg" (1 trials), "DeSyne drug eluting stent group" (1 trials), "EntecaBell ODT. 0.5mg" (1 trials) and "Sofosbuvir" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Konkuk University Chungju Hospital
The vast majority of trials in "Konkuk University Chungju Hospital" are
5 trials for "All" genders.
Clinical Trials Status at Konkuk University Chungju Hospital
Currently, there are NaN active trials in "Konkuk University Chungju Hospital".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Konkuk University Chungju Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Konkuk University Chungju Hospital, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 1 trials that are defined as “Not Applicable".